Incorporation of bioactive glass nanoparticles in electrospun PCL/chitosan fibers by using benign solvents
The use of bioactive glass (BG) particles as a filler for the development of composite electrospun fibers has already been widely reported and investigated. The novelty of the present research work is represented by the use of benign solvents (like acetic acid and formic acid) for electrospinning of...
Gespeichert in:
Veröffentlicht in: | Bioactive materials 2018-03, Vol.3 (1), p.55-63 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The use of bioactive glass (BG) particles as a filler for the development of composite electrospun fibers has already been widely reported and investigated. The novelty of the present research work is represented by the use of benign solvents (like acetic acid and formic acid) for electrospinning of composite fibers containing BG particles, by using a blend of PCL and chitosan. In this work, different BG particle sizes were investigated, namely nanosized and micron-sized. A preliminary investigation about the possible alteration of BG particles in the electrospinning solvents was performed using SEM analysis. The obtained composite fibers were investigated in terms of morphological, chemical and mechanical properties. An in vitro mineralization assay in simulated body fluid (SBF) was performed to investigate the capability of the composite electrospun fibers to induce the formation of hydroxycarbonate apatite (HCA).
[Display omitted]
•Use of benign solvents for electrospinning of composite PCL/chitosan fibers containing nano and micronsized BG particles.•Successfully dispersion of BG nano and micronsized particles in electrospun PCL/chitosan nanofibrous mats.•Deposition of hydroxycarbonate apatite after immersion in SBF solution confirmed for both composites fibers. |
---|---|
ISSN: | 2452-199X 2452-199X |
DOI: | 10.1016/j.bioactmat.2017.05.003 |